SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,799,664 | -11.8% | 188,085 | +0.3% | 1.70% | -13.3% |
Q1 2023 | $25,840,506 | +120.6% | 187,481 | +107.4% | 1.96% | +91.4% |
Q4 2022 | $11,712,736 | -13.0% | 90,390 | +14.5% | 1.03% | -1.3% |
Q4 2020 | $13,464,000 | +28.8% | 78,970 | +6.1% | 1.04% | -8.0% |
Q3 2020 | $10,450,000 | +418.6% | 74,412 | +492.1% | 1.13% | +176.3% |
Q2 2020 | $2,015,000 | -41.1% | 12,568 | -64.1% | 0.41% | -38.6% |
Q1 2020 | $3,420,000 | -25.8% | 34,963 | -2.1% | 0.67% | +40.2% |
Q4 2019 | $4,609,000 | +10.2% | 35,716 | -35.7% | 0.48% | +34.9% |
Q3 2019 | $4,182,000 | -49.2% | 55,523 | +2.5% | 0.35% | -53.4% |
Q2 2019 | $8,229,000 | +23.7% | 54,155 | -2.9% | 0.76% | +27.3% |
Q1 2019 | $6,650,000 | -17.8% | 55,791 | -24.7% | 0.59% | -31.8% |
Q4 2018 | $8,087,000 | -35.9% | 74,102 | -5.1% | 0.87% | -14.0% |
Q3 2018 | $12,616,000 | +63.0% | 78,113 | +33.4% | 1.01% | +85.8% |
Q2 2018 | $7,738,000 | +227.2% | 58,543 | +52.0% | 0.54% | +246.5% |
Q3 2016 | $2,365,000 | +21.8% | 38,504 | -24.6% | 0.16% | -13.3% |
Q2 2013 | $1,942,000 | – | 51,046 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |